These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 3018071)

  • 21. Response of embryonic chicken lymphocytes to in ovo exposure to lymphotropic viruses.
    St Hill CA; Sharma JM
    Am J Vet Res; 1999 Aug; 60(8):937-41. PubMed ID: 10451200
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine.
    Sharma JM; Graham CK
    Avian Dis; 1982; 26(4):860-70. PubMed ID: 6297450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inoculation experiment of Marek's disease vaccine contaminated with a reticuloendotheliosis virus.
    Kawamura H; Wakabayashi T; Yamaguchi S; Taniguchi T; Takayanagi N
    Natl Inst Anim Health Q (Tokyo); 1976; 16(4):135-40. PubMed ID: 189219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the specificity of the immunoglobulin G produced by chickens experimentally infected with Marek's disease virus.
    Settnes OP
    Nord Vet Med; 1985; 37(3):170-5. PubMed ID: 2993996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of blood group markers (B allele), immunoglobulins and leukosis infections on the development of Marek's disease].
    Löliger HC; von dem Hagen D; Krieg R
    Dtsch Tierarztl Wochenschr; 1986 Jan; 93(1):44-9. PubMed ID: 3009129
    [No Abstract]   [Full Text] [Related]  

  • 26. Attenuated Marek's disease herpesvirus: protection conferred on strains of chickens varying in genetic resistance.
    Spencer JL; Grunder AA; Robertson A; Speckmann GW
    Avian Dis; 1972 Apr; 16(1):94-107. PubMed ID: 4337320
    [No Abstract]   [Full Text] [Related]  

  • 27. Marek's disease virus (MDV) antigens in the feather follicle epithelium: difference between oncogenic and nononcogenic MDV.
    Rangga-Tabbu C; Cho BR
    Avian Dis; 1982; 26(4):907-17. PubMed ID: 6297453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal transfer of resistance against development of Marek's disease tumors.
    Eidson CS; Kleven SH; LaCroix VM; Anderson DP
    Avian Dis; 1972 Apr; 16(1):139-52. PubMed ID: 4337310
    [No Abstract]   [Full Text] [Related]  

  • 29. Partial protection against Marek's disease in chickens immunized with glycoproteins gB purified from turkey-herpesvirus-infected cells by affinity chromatography coupled with monoclonal antibodies.
    Ono K; Takashima M; Ishikawa T; Hayashi M; Yoshida I; Konobe T; Ikuta K; Nakajima K; Ueda S; Kato S
    Avian Dis; 1985; 29(2):533-9. PubMed ID: 3896223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigen requirements and specificity of a microplate enzyme-lined immunosorbent assay (ELISA) for Marek's disease viral antibodies in chicken, mouse and rabbit sera.
    Coudert F; Ahluwalia R
    Ann Rech Vet; 1984; 15(4):529-34. PubMed ID: 6099079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials.
    Rispens BH; van Vloten H; Mastenbroek N; Maas HJ; Schat KA
    Avian Dis; 1972 Apr; 16(1):108-25. PubMed ID: 4337307
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased susceptibility of leukemia-infected chickens to Marek's disease.
    Jakovleva LS; Mazurenko NP
    Neoplasma; 1979; 26(4):393-6. PubMed ID: 230419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term field trials with the herpesvirus of turkeys vaccine against Marek's disease.
    Purchase HG; Okazaki W; Burmester BR
    Avian Dis; 1972 Apr; 16(1):57-71. PubMed ID: 4337318
    [No Abstract]   [Full Text] [Related]  

  • 34. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
    Baigent SJ; Smith LP; Nair VK; Currie RJ
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Turkey herpesvirus and Marek's disease virus. A comparative appraisal.
    Prasad LB
    Comp Immunol Microbiol Infect Dis; 1979; 2(2-3):335-58. PubMed ID: 228905
    [No Abstract]   [Full Text] [Related]  

  • 36. Demonstration of Marek's disease tumor-associated surface antigen in chickens infected with nononcogenic Marek's disease virus and herpesvirus of turkeys.
    Schat KA; Calnek BW
    J Natl Cancer Inst; 1978 Sep; 61(3):855-7. PubMed ID: 211242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marek's disease vaccine: its implications in biology and medicine.
    Hilleman MR
    Avian Dis; 1972 Apr; 16(1):191-9. PubMed ID: 4337314
    [No Abstract]   [Full Text] [Related]  

  • 38. [Significance of virus-neutralizing antibodies in Marek's disease of chickens. 1. Immunity control following Marek's vaccination with turkey Herpes Virus (THV)].
    von dem Hagen D; Löliger HC
    Dtsch Tierarztl Wochenschr; 1978 Jun; 85(6):220-2. PubMed ID: 207505
    [No Abstract]   [Full Text] [Related]  

  • 39. Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens.
    Lee LF; Liu X; Witter RL
    J Immunol; 1983 Feb; 130(2):1003-6. PubMed ID: 6184394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bursal lesions in chickens inoculated with Marek's disease vaccines.
    Fletcher OJ; Eidson CS; Kleven SH
    Avian Dis; 1972 Apr; 16(1):153-62. PubMed ID: 4112693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.